Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

Item
http://www.wikidata.org/entity/Q34604533
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation.Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Stroke prevention with rivaroxaban in higher-risk populations with atrial fibrillation.Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review.Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed.Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
P2860

Cost effectiveness of new oral anticoagulants for stroke prevention in patients with atrial fibrillation in two different European healthcare settings

Item
http://www.wikidata.org/entity/Q34604533
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost effectiveness of new oral ...... t European healthcare settings
@ast
Cost effectiveness of new oral ...... t European healthcare settings
@en
Cost effectiveness of new oral ...... t European healthcare settings
@nl
type
label
Cost effectiveness of new oral ...... t European healthcare settings
@ast
Cost effectiveness of new oral ...... t European healthcare settings
@en
Cost effectiveness of new oral ...... t European healthcare settings
@nl
prefLabel
Cost effectiveness of new oral ...... t European healthcare settings
@ast
Cost effectiveness of new oral ...... t European healthcare settings
@en
Cost effectiveness of new oral ...... t European healthcare settings
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Cost effectiveness of new oral ...... t European healthcare settings
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932